scispace - formally typeset
L

Linda Nichols

Researcher at University of Birmingham

Publications -  27
Citations -  1651

Linda Nichols is an academic researcher from University of Birmingham. The author has contributed to research in topics: Population & Standardized mortality ratio. The author has an hindex of 18, co-authored 26 publications receiving 1304 citations. Previous affiliations of Linda Nichols include University of Warwick.

Papers
More filters
Journal ArticleDOI

Development and validation of an electronic frailty index using routine primary care electronic health record data

TL;DR: Routine implementation of the eFI could enable delivery of evidence-based interventions to improve outcomes for this vulnerable group of older people with mild, moderate and severe frailty, with robust predictive validity for outcomes of mortality, hospitalisation and nursing home admission.
Journal ArticleDOI

The effect of walking on risk factors for cardiovascular disease: An updated systematic review and meta-analysis of randomised control trials

TL;DR: A systematic review and meta-analysis of randomised control trials that examined the effect of walking on risk factors for cardiovascular disease underscores the central role of walking in physical activity for health promotion.
Journal ArticleDOI

Osteoarthritis and meniscus disorders of the knee as occupational diseases of miners

TL;DR: There was sufficient evidence to conclude that work involving kneeling and/or squatting is causally associated with an increased risk of osteoarthritis of the knee, and in some of the more recent epidemiologically sound studies, frequent or prolonged kneeling or squatting doubles the general risk of arthritis found in the general population.
Journal ArticleDOI

Survival following a diagnosis of heart failure in primary care

TL;DR: In a primary care population, the survival of patients diagnosed with heart failure did not improved over time and further research is needed to explain these trends and to find strategies to improve outlook.
Journal ArticleDOI

Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo

TL;DR: Growing evidence implicates iron in the aetiology of gastrointestinal cancer, and studies demonstrate that iron chelators possess potent anti‐tumour activity, although whether iron che lators show activity against oesophageal cancer is not known.